Abstract
Aim: This paper aimed to identify the differentially expressed proteins (DEPs) in Calu-3 cells infected by influenza A virus (IAV) subtype H5N1. Methods: We downloaded proteome data (BTO: 0000762) from the Proteomics Identifications database and identified the DEPs in the IAV-infected Calu-3 cells. Then we constructed a protein-protein interaction network and a transcriptional regulatory network of the proteins. Finally, we performed gene ontology (GO) analysis to study the IAV infection at a functional level. Results: A total of 4 protein groups between the normal cells and the Calu-3 cells infected by IAV, severe acute respiratory syndrome or swine influenza were identified. In the networks, we found 5 significant proteins including FAN, CPSF2, AGO1, AGO2 and PAX5. In addition, we demonstrated those proteins were associated with GO terms such as phosphate metabolic process, calcium ion transport, cell division and regulation of cell motion. STAT1, NS2, CD5, NCKX6 and PDGFB were significant DEPs in these GO terms. Conclusions: By referring to the previous studies, we suggest that proteins including FAN, CPSF2, AGO1, AGO2, PAX5, STAT1 and PDGFB can be used as therapeutic targets of IAV infection.
Journal Section:
Research Article
References
1.
Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Krönke M: FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996;86:937-947.
[PubMed]
2.
Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE: CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 1998;188:2301-2311.
[PubMed]
3.
Barik S: siRNA for influenza therapy. Viruses 2010;2:1448-1457.
[PubMed]
4.
Beigel JH, Farrar J, Han A, Hayden F, Hyer R, De Jong M, Lochindarat S, Nguyen T, Nguyen T, Tran T: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374.
[PubMed]
5.
Bluthé RM, Layé S, Michaud B, Combe C, Dantzer R, Parnet P: Role of interleukin-1β and tumour necrosis factor-α in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 2000;12:4447-4456.
[PubMed]
6.
Carafoli E: Intracellular calcium homeostasis. Annu Rev Biochem 1987;56:395-433.
[PubMed]
7.
Chan PK: Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002;34:S58-S64.
[PubMed]
8.
Chatr-aryamontri A, Ceol A, Peluso D, Nardozza A, Panni S, Sacco F, Tinti M, Smolyar A, Castagnoli L, Vidal M: VirusMINT: a viral protein interaction database. Nucl Acids Res 2009;37:D669-D673.
[PubMed]
9.
Cobaleda C, Schebesta A, Delogu A, Busslinger M: Pax5: the guardian of B cell identity and function. Nat Immunol 2007;8:463-470.
[PubMed]
10.
Csardi G, Nepusz T: The iGraph software package for complex network research. InterJournal Complex Systems 2006, p 1695.
11.
de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
[PubMed]
12.
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
[PubMed]
13.
Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A: The UCSC Genome Browser database: update 2011. Nucl Acids Res 2011;39:D876-D882.
[PubMed]
14.
Fujita Y, Maruyama S, Kogo H, Matsuo S, Fujimoto T: Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int 2004;66:1794-1804.
[PubMed]
15.
Ge Q, Pastey M, Kobasa D, Puthavathana P, Lupfer C, Bestwick RK, Iversen PL, Chen J, Stein DA: Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrob Agents Chemother 2006;50:3724-3733.
[PubMed]
16.
Grossman Z, Herberman RB, Dimitrov DS: T cell turnover in SIV infection. Science 1999;284:555-555.
17.
Guerini D, Coletto L, Carafoli E: Exporting calcium from cells. Cell Calcium 2005;38:281-289.
[PubMed]
18.
Hazenberg MD, Stuart JWC, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D: T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000;95:249-255.
[PubMed]
19.
Hosoya M, Nunoi H, Aoyama M, Kawasaki Y, Suzuki H: Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J 2005;24:467-470.
[PubMed]
20.
Ito Y, Torii Y, Ohta R, Imai M, Hara S, Kawano Y, Matsubayashi T, Inui A, Yoshikawa T, Nishimura N: Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children. Cytokine 2011;56:180-187.
[PubMed]
21.
Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS, Minna JD, Corey DR: Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 2006;13:787-792.
[PubMed]
22.
Kaufmann I, Martin G, Friedlein A, Langen H, Keller W: Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly (A) polymerase. EMBO J 2004;23:616-626.
[PubMed]
23.
Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T: Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 2003;188:690-698.
[PubMed]
24.
Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994;77:325-328.
[PubMed]
25.
Kolev NG, Yario TA, Benson E, Steitz JA: Conserved motifs in both CPSF73 and CPSF100 are required to assemble the active endonuclease for histone mRNA 3′-end maturation. EMBO Rep 2008;9:1013-1018.
[PubMed]
26.
Krönke M: Involvement of sphingomyelinases in TNF signaling pathways. Chem Phys Lipids 1999;102:157-166.
[PubMed]
27.
Lai YH, Li ZC, Chen LL, Dai Z, Zou XY: Identification of potential host proteins for influenza A virus based on topological and biological characteristics by proteome-wide network approach. J Proteomics 2012;75:2500-2513.
[PubMed]
28.
Lawrence CW, Braciale TJ: Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 2004;173:1209-1218.
[PubMed]
29.
Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ: Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004;305:1437-1441.
[PubMed]
30.
Ma J, Sun Q, Mi R, Zhang H: Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genom 2011;38:533-537.
[PubMed]
31.
MacPherson JI, Dickerson JE, Pinney JW, Robertson DL: Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems. PLoS Comput Biol 2010;6:e1000863.
[PubMed]
32.
Mandel CR, Bai Y, Tong L: Protein factors in pre-mRNA 3′-end processing. Cell Mol Life Sci 2008;65:1099-1122.
[PubMed]
33.
Noah DL, Twu KY, Krug RM: Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 2003;307:386-395.
[PubMed]
34.
Omilusik K, Priatel JJ, Chen X, Wang YT, Xu H, Choi KB, Gopaul R, McIntyre-Smith A, Teh H-S, Tan R: The Ca(v)1.4 calcium channel is a critical regulator of T cell receptor signaling and naive T cell homeostasis. Immunity 2011;35:349-360.
[PubMed]
35.
Österlund P, Veckman V, Sirén J, Klucher KM, Hiscott J, Matikainen S, Julkunen I: Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005;79:9608-9617.
[PubMed]
36.
Palin K, Bluthé R-M, McCusker RH, Levade T, Moos F, Dantzer R, Kelley KW: The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFα-induced sickness behavior. Psychopharmacology 2009;201:549-556.
[PubMed]
37.
Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC: The genomic and epidemiological dynamics of human influenza A virus. Nature 2008;453:615-619.
[PubMed]
38.
Richardson J, Akkina R: NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch Virol 1991;116:69-80.
[PubMed]
39.
Ricono JM, Wagner B, Gorin Y, Arar M, Kazlauskas A, Choudhury GG, Abboud HE: PDGF receptor-β modulates metanephric mesenchyme chemotaxis induced by PDGF AA. Am J Physiol Renal Physiol 2009;296:F406-F417.
[PubMed]
40.
Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM: Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010;141:290-303.
[PubMed]
41.
Schmolke M, Viemann D, Roth J, Ludwig S: Essential impact of NF-κB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol 2009;183:5180-5189.
[PubMed]
42.
Ségui B, Cuvillier O, Adam-Klages S, Garcia V, Malagarie-Cazenave S, Lévêque S, Caspar-Bauguil S, Coudert J, Salvayre R, Krönke M: Involvement of FAN in TNF-induced apoptosis. J Clin Invest 2001;108:143-151.
[PubMed]
43.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504.
[PubMed]
44.
Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE: A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009;139:1255-1267.
[PubMed]
45.
van Dijk D, Ertaylan G, Boucher C, Sloot P: Identifying potential survival strategies of HIV-1 through virus-host protein interaction networks. BMC Syst Biol 2010;4:96.
[PubMed]
46.
Van Stry M, Oguin TH, Cheloufi S, Vogel P, Watanabe M, Pillai MR, Dash P, Thomas PG, Hannon GJ, Bix M: Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection. J Virol 2012;86:4151-4157.
[PubMed]
47.
Vandenabeele P, Declercq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995;5:392-399.
[PubMed]
48.
Veckman V, Österlund P, Fagerlund R, Melén K, Matikainen S, Julkunen I: TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006;345:96-104.
[PubMed]
49.
Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM: Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals. J Cell Sci 2011;124:1288-1300.
[PubMed]
50.
Vizcaíno JA, Côté R, Reisinger F, Barsnes H, Foster JM, Rameseder J, Hermjakob H, Martens L: The proteomics identifications database: 2010 update. Nucl Acids Res 2010;38:D736-D742.
[PubMed]
51.
Ward SE, Kim HS, Komurov K, Mendiratta S, Tsai P-L, Schmolke M, Satterly N, Manicassamy B, Forst CV, Roth MG: Host modulators of H1N1 cytopathogenicity. PloS One 2012;7:e39284.
[PubMed]
52.
Wright PF, Webster RG: Orthomyxoviruses. Fields Virol 2001;1:1533-1579.
53.
Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, Cesareni G: MINT: a Molecular INTeraction database. FEBS Lett 2002;513:135-140.
[PubMed]
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.
